Quetiapine Fumarate
Product Images NDC 69189-0580

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 69189-0580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine 400 mg Tablet (6918905801)

This is a description of a medication called Quetiapine with a strength of 400mg, in the form of a tablet. The manufacturer is Ascend, and the pills were produced under the lot number 5140661. The medication was received in a hospital under lot number APF16211-G, and it has an expiration date of 03/11/2017. The National Drug Code (NDC) for the medication is 6918905801. There is a reference to Avera McKennan hospital, which may be the location that received or administered the medication.*

FDA Label Image

Figure 1 (Quetiapine Fig1)

The text describes a figure that shows a graph of the proportion of patients with relapse over time in a study. The graph is represented by Kaplan-Mcier curves and the time is measured in weeks. The figure has a scale from 0 to 100 and shows different levels of relapse rates throughout the study.*

FDA Label Image

Figure 2 (Quetiapine Fig2)

This is a graph showing the proportion of patients with relapse over time (in weeks) using Kaplan-Meier curves for a study on recurrence of a mood event.*

FDA Label Image

Structure (Quetiapine Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.